Sector pending / Pharmaceutical PreparationsUpdated 2026-05-10 22:07 UTC

KOSDAQ/018680 stock hub

KOSDAQ/018680 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

KOSDAQ/018680is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

31.8B

KOSDAQ

Market data

Live price

Current market quote for this ticker.

Current price

KOSDAQ/018680

In the news

Latest news · KOSDAQ/018680

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/E42.2

P25 n/aP50 n/aP75 n/a

ROE1.9

P25 n/aP50 n/aP75 n/a

ROIC-2.6

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All KOSDAQ/018680 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

189

Groups with data

Currency

KRW

Showing 189 of 189 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	South Korea
Country code	KR
Employees	172
Enterprise value	KRW 39.2B
Exchange	KOSDAQ
Financial currency	KRW
First seen	2026-05-10
Industry	Pharmaceutical Preparations
Last refreshed	2026-05-10
Market cap	KRW 31.8B
Price	KRW 2,725
Price currency	KRW
Rev Per Employee	303,193,657.67x
Sic	2834
Symbol	kosdaq/018680
Website	https://www.seoulpharma.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	2.37%
EV Earnings	52.03x
EV/EBITDA	28.36x
EV/FCF	38.28x
EV/Sales	0.75x
FCF yield	3.22%
P/B ratio	0.77x
P/E ratio	42.16x
P/S ratio	0.61x
PE Ratio3 Y	28.84x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-2.45%
EBITDA Margin	2.65%
FCF margin	1.96%
Gross margin	60.41%
Gross Profit	KRW 31.5B
Gross Profit Growth	-4.33%
Gross Profit Growth Q	-8.48%
Gross Profit Growth3 Y	-0.67%
Gross Profit Growth5 Y	-2.21%
Net Income	KRW 753.6M
Net Income Growth	-55.63%
Net Income Growth3 Y	-4.12%
Pretax Margin	1.21%
Profit Margin	1.45%
Profit Per Employee	KRW 4.4M
ROA	-1.12
Roa5y	-0.47
ROCE	-2.25
ROE	1.86
Roe5y	-4.34
ROIC	-2.56
Roic5y	-1.4

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-16.55%
Cagr15y	1%
Cagr1y	-19.63%
Cagr20y	1.45%
Cagr3y	-13.43%
Cagr5y	-20.97%
Div CAGR10	0%
FCF Growth5 Y	-27.97%
OCF Growth10 Y	2.87%
OCF Growth5 Y	-19.95%
Revenue Growth	-2.67x
Revenue Growth Q	-2.05x
Revenue Growth3 Y	1.37x
Revenue Growth5 Y	-0.03x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	KRW 0.73
Assets	KRW 71.8B
Cash	KRW 9.9B
Current Assets	KRW 34B
Current Liabilities	KRW 14.9B
Debt	KRW 17.4B
Debt EBITDA	KRW 12.58
Debt Equity	KRW 0.42
Debt FCF	KRW 16.98
Equity	KRW 41B
Interest Coverage	-2.22
Liabilities	KRW 30.7B
Long Term Assets	KRW 37.7B
Long Term Liabilities	KRW 15.8B
Net Cash	KRW -7.4B
Net Cash By Market Cap	KRW -23.43
Net Debt EBITDA	KRW 5.38
Net Debt Equity	KRW 0.18
Net Debt FCF	KRW 7.27
Tangible Book Value	KRW 40.2B
WACC	5.5

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	2.28
Inventory Turnover	1.75
Net Working Capital	KRW 14.9B
Quick ratio	1.51
Working Capital	KRW 19.1B
Working Capital Turnover	KRW 2.8

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Dividend per share	KRW 0
Last Dividend	KRW 15

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-83.62%
1Y total return	-19.62%
200-day SMA	3,033.2
3Y total return	-35.12%
50-day SMA	2,744.7
50-day SMA vs 200-day SMA	50under200
5Y total return	-69.17%
All Time High	27,800
All Time High Change	-90.2%
All Time High Date	2015-06-03
All Time Low	890
All Time Low Change	206.18%
All Time Low Date	2004-08-04
ATR	104.4
Beta	0.51
Beta1y	0.21
Beta2y	0.18
Ch YTD	-11.53
High	2,805
High52	4,205
High52 Date	2025-05-22
High52ch	-35.2%
Low	2,650
Low52	2,310
Low52 Date	2026-03-04
Low52ch	17.97%
Ma50ch	-0.72%
Price vs 200-day SMA	-10.16%
RSI	40.57
RSI Monthly	35.69
RSI Weekly	39.01
Sharpe ratio	-0.66x
Sortino ratio	-0.73
Tr YTD	-11.53
Tr15y	16.14%
Tr1m	0.74%
Tr1w	-3.37%
Tr3m	-3.88%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	KRW -1.3B
Operating margin	-2.45

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	4,724,517%
Net Borrowing	1,327,613,390
Shares Insiders	0.07%
Shares Out	11,659,319

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	KRW 1B
Average Volume	11,305.95x
CAPEX	KRW -861.3M
Ch10y	-83.73
Ch15y	12.14
Ch1m	0.74
Ch1w	-3.37
Ch1y	-19.62
Ch20y	24.43
Ch3m	-3.88
Ch3y	-35.12
Ch5y	-69.17
Ch6m	-6.03
Change	-0.18%
Change From Open	-2.85
Close	2,730
Days Gap	2.75
Depreciation Amortization	2,662,131,000
Dollar Volume	9,880,850
EBIT	KRW -1.3B
EBITDA	KRW 1.4B
F Score	4
FCF	KRW 1B
FCF EV Yield	2.61x
FCF Per Share	KRW 87.87
Financing CF	1,327,613,380
Fiscal Year End	December
Founded	1,976
Income Tax	KRW -122.1M
Investing CF	-842,966,320
Is Primary Listing	1
Last Report Date	2025-12-31
Last Split Date	2004-04-12
Last Split Type	Forward
Ma150	2,942.2
Ma150ch	-7.38%
Ma20	2,825.8
Ma20ch	-3.57%
Net CF	2,408,489,810
Open	2,805
P FCF Ratio	31.01
P OCF Ratio	16.85
Position In Range	48.39
Ppne	32,124,369,180
Price Date	2026-05-08
Price EBITDA	KRW 22.98
Ptbv Ratio	0.79
Relative Volume	0.32x
Revenue	52,149,309,120x
Tax By Revenue	-0.23x
Tr20y	33.33%
Tr6m	-6.03%
Volume	3,626
Z Score	1.85

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does KOSDAQ/018680 pay a dividend?

Capital-return profile for this ticker.

Performance

KOSDAQ/018680 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns KOSDAQ/018680?

Insider, institutional, and short-interest positioning.

Institutional ownership

n/a

Share of float held by funds and institutions

Insider ownership

+0.1%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

n/a

Negative means the company is buying back shares.

Technical

KOSDAQ/018680 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

40.6

Neutral momentum band

Price vs 200-day MA

-10.2%

50/200-day relationship not available

Beta (5Y)

0.51

Less volatile than the market

Sharpe ratio

-0.66

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About KOSDAQ/018680

Hub-level FAQ points readers to the deeper analysis pages.

What is the current kosdaq/018680 stock rating?

kosdaq/018680 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full kosdaq/018680 analysis?

The full report lives at /stocks/kosdaq/018680/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for kosdaq/018680?

The latest report frames kosdaq/018680 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the kosdaq/018680 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.